Monday, January 24, 2011

Monday's Product Headlines - FDA

European Medicines AgencyImage via WikipediaHere's a quick summary of products in the news this morning, 11/24/11:

The European Medicines Agency (EMA) issued a release saying that it would review the safety of heart drug Multaq after two cases of liver failure in patients on the drug. Link here. 

The FDA says that HCG weight loss products are fraudulent. Link here.

FDA considers more stringent rules on defibrillators. Link here

Dialysis Set recalled recently gets a Class 1 recall designation: Link
Enhanced by Zemanta